These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 819792)

  • 1. [Clinical experience with Arwin (author's transl)].
    Hess H; Keil-Kuri E; Marshall M
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1317-20. PubMed ID: 819792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
    Heidrich H
    Med Klin; 1978 May; 73(21):798-800. PubMed ID: 651769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H; Schmidt P; Hüttel E
    MMW Munch Med Wochenschr; 1978 Nov; 120(45):1501-4. PubMed ID: 101819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):387-92. PubMed ID: 786664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA; Goyle KB
    Br J Surg; 1976 Aug; 63(8):661-2. PubMed ID: 953495
    [No Abstract]   [Full Text] [Related]  

  • 7. SDS polyacrylamide gel characterization of serum FDP produced in response to ancrod and streptokinase/plasminogen infusion in man.
    Lane DA; Robbins A; Rampling MW; Kakkar VV
    Br J Haematol; 1977 May; 36(1):137-48. PubMed ID: 871418
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological treatment of chronic arterial occlusive disease (author's transl)].
    Dittrich J; Spaan G; Stein U; Wagner E; Frese JH
    Med Klin; 1979 Sep; 74(39):1396-403. PubMed ID: 492058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late lysis therapy of chronic arterial occlusion. A new way to improve results (author's transl)].
    Müller-Fassbender H; Hess H
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1461-2. PubMed ID: 810668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential treatment of arterial occlusions with porcine plasmin and low dose streptokinase.
    Marbet GA; Eichlisberger R; Duckert F; da Silva MA; Biland L; Widmer LK; Ritz R; Schmitt HE
    Thromb Haemost; 1982 Oct; 48(2):187-9. PubMed ID: 6217580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with Arvin therapy in aged patients].
    Landgraf H; Stumpf J; Knecht H; Raithel D
    Ther Ggw; 1979 Mar; 118(3):375-86. PubMed ID: 432855
    [No Abstract]   [Full Text] [Related]  

  • 12. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Defibrination treatment of progressive scleroderma].
    Klüken N; Tiedjen KU
    Phlebologie; 1979; 32(1):79-83. PubMed ID: 432294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course].
    Heidrich H
    ZFA (Stuttgart); 1978 Nov; 54(32):1648-51. PubMed ID: 735320
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic defibrination by arwin in unstable angina pectoris combined with hyperfibrinogenaemia (author's transl)].
    Spöttl F; Pimmingstorfer E; Froschauer J
    Wien Klin Wochenschr; 1978 Nov; 90(22):792-6. PubMed ID: 716435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of the sequential use of streptokinase and ancrod in the treatment of deep vein thrombosis of lower limb.
    Tibbutt DA; Chesterman CN; Williams EW; Faulkner T; Sharp AA
    Thromb Haemost; 1977 Apr; 37(2):222-32. PubMed ID: 577626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of digitalis on hemodynamics during rest in patients with arterial occlusive diseases, stage II, without cardiac insufficiency].
    Brecht T; Bodem G; Schäfer E
    Schweiz Med Wochenschr; 1982 Jan; 112(4):111-4. PubMed ID: 7063821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease.
    Staiger J; Konrad-Graf S; Keil G
    Bibl Haematol; 1981; (47):252-7. PubMed ID: 7337665
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indoor treatment of involutional depressions in cerebro-vascular insufficiency (author's transl)].
    Hebenstreit G; Papadopulos P
    Aktuelle Gerontol; 1979 May; 9(5):223-30. PubMed ID: 37759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Defibrination in the therapy of arterial occlusive diseases].
    Böhme H
    ZFA (Stuttgart); 1978 Nov; 54(32):1644-7. PubMed ID: 735319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.